Results 251 to 260 of about 3,597,475 (336)
Psychiatric Disorders and Apathy in Mixed Movement Disorders Linked to ADCY5 (MxMD‐ADCY5)
Abstract Background Mixed movement disorders linked to ADCY5 (MxMD‐ADCY5) represent a rare hyperkinetic movement disorder resulting from pathogenic variants in ADCY5. Psychiatric symptoms are suspected to be part of the phenotype. Objective The study aim was to assess psychiatric comorbidities in patients with MxMD‐ADCY5.
Aurélie Méneret +23 more
wiley +1 more source
Differential Impact of Depression and Psychotic Disorders on Complications, Costs, and Discharge After Single-Level Lumbar Fusion. [PDF]
Ng MK +17 more
europepmc +1 more source
Abstract Background Serotonergic and dopaminergic pathways are implicated in Parkinson's disease psychosis (PDP), but preliminary evidence also implicates the endocannabinoid system (ECS). Objectives We examined the association of gray matter volume loss in PDP patients with brain expression of the genes coding for CB1 (cannabinoid type 1) and CB2 ...
Sara Pisani +3 more
wiley +1 more source
Pharmacotherapy of Psychotic Disorders in Türkiye: Insights From a National Prescription Database. [PDF]
Türkeş S +5 more
europepmc +1 more source
Perspective: Depression in Persons with Parkinson's Disease
Abstract Depression is a prevalent and disabling syndrome characterized by sustained sadness and/or anhedonia, as well as cognitive and physical symptoms. In Parkinson's disease (PD), depression is both common and clinically challenging due to overlapping symptoms and complex etiologic interactions. Major depressive disorder occurs in approximately 17%
Albert F.G. Leentjens +1 more
wiley +1 more source
Development and validation of a machine learning model to identify individuals at high risk for psychotic disorders using medical record data. [PDF]
Marafino BJ +11 more
europepmc +1 more source
Validation of the German Version of the Movement Disorder Society Non‐Motor Scale (MDS‐NMS)
Movement Disorders Clinical Practice, EarlyView.
Jonas Bendig +20 more
wiley +1 more source
Abstract Background Transcranial temporal interference stimulation (TIs) targeting the subthalamic nucleus (STN) is a novel noninvasive neuromodulation approach with potential to improve motor symptoms in Parkinson's disease (PD). However, its underlying neuroimaging mechanisms remain unclear.
Yongxin Xu +19 more
wiley +1 more source

